These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 27075590)
1. HSP90 Inhibition Suppresses PGE2 Production via Modulating COX-2 and 15-PGDH Expression in HT-29 Colorectal Cancer Cells. Mohammadi A; Yaghoobi MM; Gholamhoseinian Najar A; Kalantari-Khandani B; Sharifi H; Saravani M Inflammation; 2016 Jun; 39(3):1116-23. PubMed ID: 27075590 [TBL] [Abstract][Full Text] [Related]
2. HSP90 inhibitor enhances anti-proliferative and apoptotic effects of celecoxib on HT-29 colorectal cancer cells via increasing BAX/BCL-2 ratio. Mohammadi A; Yaghoobi MM; GholamhoseynianNajar A; Kalantari-Khandani B; Sharifi H; Saravani M Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):62-67. PubMed ID: 27894402 [TBL] [Abstract][Full Text] [Related]
3. Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Holmes JL; Sharp SY; Hobbs S; Workman P Cancer Res; 2008 Feb; 68(4):1188-97. PubMed ID: 18281495 [TBL] [Abstract][Full Text] [Related]
4. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells. Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428 [TBL] [Abstract][Full Text] [Related]
5. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells. Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590 [TBL] [Abstract][Full Text] [Related]
6. Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease. Dai L; King DW; Perera DS; Lubowski DZ; Burcher E; Liu L Dig Dis Sci; 2015 May; 60(5):1236-46. PubMed ID: 25666316 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504 [TBL] [Abstract][Full Text] [Related]
8. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer. Monteleone NJ; Moore AE; Iacona JR; Lutz CS; Dixon DA Sci Rep; 2019 Apr; 9(1):5405. PubMed ID: 30931980 [TBL] [Abstract][Full Text] [Related]
11. Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells. Cheung CH; Chen HH; Cheng LT; Lyu KW; Kanwar JR; Chang JY Mol Cancer; 2010 Apr; 9():77. PubMed ID: 20398291 [TBL] [Abstract][Full Text] [Related]
12. HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells. Ko JC; Chen HJ; Huang YC; Tseng SC; Weng SH; Wo TY; Huang YJ; Chiu HC; Tsai MS; Chiou RY; Lin YW Regul Toxicol Pharmacol; 2012 Dec; 64(3):415-24. PubMed ID: 23069143 [TBL] [Abstract][Full Text] [Related]
13. Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment. Talaei S; Mellatyar H; Asadi A; Akbarzadeh A; Sheervalilou R; Zarghami N Chem Biol Drug Des; 2019 May; 93(5):760-786. PubMed ID: 30697932 [TBL] [Abstract][Full Text] [Related]
14. FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases. Yao Q; Nishiuchi R; Li Q; Kumar AR; Hudson WA; Kersey JH Clin Cancer Res; 2003 Oct; 9(12):4483-93. PubMed ID: 14555522 [TBL] [Abstract][Full Text] [Related]
15. The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression. Georgakis GV; Li Y; Rassidakis GZ; Medeiros LJ; Younes A Exp Hematol; 2006 Dec; 34(12):1670-9. PubMed ID: 17157164 [TBL] [Abstract][Full Text] [Related]
16. The Hsp90 inhibitor 17-allylamide-17-demethoxygeldanamycin induces apoptosis and differentiation of Kasumi-1 harboring the Asn822Lys KIT mutation and down-regulates KIT protein level. Yu W; Rao Q; Wang M; Tian Z; Lin D; Liu X; Wang J Leuk Res; 2006 May; 30(5):575-82. PubMed ID: 16213582 [TBL] [Abstract][Full Text] [Related]
17. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Guo F; Rocha K; Bali P; Pranpat M; Fiskus W; Boyapalle S; Kumaraswamy S; Balasis M; Greedy B; Armitage ES; Lawrence N; Bhalla K Cancer Res; 2005 Nov; 65(22):10536-44. PubMed ID: 16288046 [TBL] [Abstract][Full Text] [Related]
18. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines. Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615 [TBL] [Abstract][Full Text] [Related]
19. A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells. Mehdawi LM; Satapathy SR; Gustafsson A; Lundholm K; Alvarado-Kristensson M; Sjölander A Oncotarget; 2017 May; 8(21):35033-35047. PubMed ID: 28402256 [TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells. Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]